MedPath

Acute Exercise Intervention in Breast Cancer Survivors

Not Applicable
Terminated
Conditions
Breast Carcinoma
Interventions
Other: Resting
Behavioral: Exercise Intervention
Other: Biomarker Analysis
Other: Questionnaire Administration
Registration Number
NCT03779867
Lead Sponsor
Fred Hutchinson Cancer Center
Brief Summary

This trial studies how a 45-minute bout of acute exercise in women with a history of breast cancer can affect factors associated with breast cancer and help doctors learn more about how exercise can help prevent breast cancer.

In an earlier part of the study, investigators looked at the effects of the same intervention in women without a history of cancer.

Detailed Description

OUTLINE: Participants are randomized to 1 of 2 arms.

ARM I: Participants undergo a moderate-intensity acute exercise bout over 45 minutes.

ARM II: Participants rest by sitting for 45 minutes.

EXTENSION: After completion of initial study recruitment and data collection, an extension was approved in 2023.

EXTENSION OUTLINE: Participants are randomized to 1 of 2 arms.

EXTENSION ARM I: Participants exercise on a stationary bike for 45 minutes.

EXTENSION ARM II: Participants rest by sitting for 45 minutes.

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
112
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arm I (acute exercise)Questionnaire AdministrationParticipants undergo a moderate-intensity acute exercise bout over 45 minutes.
Arm II (rest)RestingParticipants rest by sitting for 45 minutes.
Arm II (rest)Biomarker AnalysisParticipants rest by sitting for 45 minutes.
Arm I (acute exercise)Exercise InterventionParticipants undergo a moderate-intensity acute exercise bout over 45 minutes.
Arm I (acute exercise)Biomarker AnalysisParticipants undergo a moderate-intensity acute exercise bout over 45 minutes.
Arm II (rest)Questionnaire AdministrationParticipants rest by sitting for 45 minutes.
Primary Outcome Measures
NameTimeMethod
Change in Plasminogen activator inhibitor type-1 (PAI-1) levelBaseline up to 45 minutes

Will compare changes in PAI-1 level from baseline to 45 minutes between the exercisers and controls.

Change in PAI-1 levelBaseline up to 105 minutes

Will compare changes in PAI-1 level from baseline to 105 minutes between the exercisers and controls.

Change in Vascular Endothelial Growth Factor (VEGF) levelBaseline up to 45 minutes

Will compare changes in VEGF level from baseline to 45 minutes between the exercisers and controls.

Mean change in homeostatic model assessment of insulin resistance (HOMA-IR)Baseline up to 45 minutes

Will compare the average changes in HOMA-IR from baseline to 45 minutes between the exercisers and controls.

Mean change in HOMA-IRBaseline up to 105 minutes

Will compare the average changes in HOMA-IR from baseline to 105 minutes between the exercisers and controls.

Change in insulin levelBaseline up to 105 minutes

Will compare changes in insulin level from baseline to 105 minutes between the exercisers and controls.

Change in glucose levelBaseline up to 105 minutes

Will compare changes in glucose level from baseline to 105 minutes between the exercisers and controls.

Change in VEGF levelBaseline up to 105 minutes

Will compare changes in VEGF level from baseline to 105 minutes between the exercisers and controls.

Change in Irisin levelBaseline up to 105 minutes

Will compare changes in Irisin level from baseline to 105 minutes between the exercisers and controls.

Secondary Outcome Measures
NameTimeMethod
Effects of exercise on HOMA-IR in normal-weight participantsAt 45 minutes

Will use the generalized estimating equations (GEE) model including the potential effect modification of weight category (normal weight versus \[vs\] overweight/obese) to compare the 45-minute exercise session on HOMA-IR in normal-weight versus overweight/obese women.

Effects of exercise on HOMA-IR in overweight/obese participantsAt 45 minutes

Will use the GEE model including the potential effect modification of weight category (normal weight versus \[vs.\] overweight/obese) to compare the 45-minute exercise session on HOMA-IR in normal-weight versus overweight/obese women.

Change in C-reactive protein (CRP)Baseline up to 105 minutes

Will compare changes in CRP level from baseline to 105 minutes between the exercisers and controls.

Change in Monocyte chemotactic protein (MCP)-1Baseline up to 105 minutes

Will compare changes in MCP-1 level from baseline to 105 minutes between the exercisers and controls.

Change in Interleukin (IL)-6Baseline up to 105 minutes

Will compare changes in IL-6 level from baseline to 105 minutes between the exercisers and controls.

Trial Locations

Locations (1)

Fred Hutch/University of Washington Cancer Consortium

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath